OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits?
Ted J. Kaptchuk, Franklin G. Miller
BMJ (2018), pp. k3889-k3889
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Placebo and Nocebo Effects
Luana Colloca, Arthur J. Barsky
New England Journal of Medicine (2020) Vol. 382, Iss. 6, pp. 554-561
Closed Access | Times Cited: 487

Exercise and education versus saline injections for knee osteoarthritis: a randomised controlled equivalence trial
Elisabeth Bandak, Robin Christensen, Anders Overgaard, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 4, pp. 537-543
Closed Access | Times Cited: 271

Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice
Ted J. Kaptchuk, Christopher C. Hemond, Franklin G. Miller
BMJ (2020), pp. m1668-m1668
Open Access | Times Cited: 156

Effects of open-label placebos in clinical trials: a systematic review and meta-analysis
Melina von Wernsdorff, Martin Loef, Brunna Tuschen‐Caffier, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 118

Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial
Julian Kleine‐Borgmann, Katharina Schmidt, Andreas Hellmann, et al.
Pain (2019) Vol. 160, Iss. 12, pp. 2891-2897
Closed Access | Times Cited: 94

Psychological Interventions for the Treatment of Chronic Pain in Adults
Mary Driscoll, Robert R. Edwards, William C. Becker, et al.
Psychological Science in the Public Interest (2021) Vol. 22, Iss. 2, pp. 52-95
Closed Access | Times Cited: 80

Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial
Anthony Lembo, John M. Kelley, Judy Nee, et al.
Pain (2021) Vol. 162, Iss. 9, pp. 2428-2435
Open Access | Times Cited: 79

Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Matthew Butler, Luke A. Jelen, James Rucker
Psychopharmacology (2022) Vol. 239, Iss. 10, pp. 3047-3055
Open Access | Times Cited: 55

Cellular signaling pathways as plastic, proto-cognitive systems: Implications for biomedicine
Juanita Mathews, Alan L. Chang, L.M. Devlin, et al.
Patterns (2023) Vol. 4, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 30

Open-label placebos—a systematic review and meta-analysis of experimental studies with non-clinical samples
Lukas Spille, Johannes C. Fendel, Patrik D. Seuling, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23

Noble Humbug? Hard and soft laws on clinical placebo use
Marc J. Richard, Michael L. Ganz, Lena Dominique Hornstein, et al.
Frontiers in Psychology (2025) Vol. 16
Open Access | Times Cited: 1

Placebos without deception reduce self-report and neural measures of emotional distress
Darwin A. Guevarra, Jason S. Moser, Tor D. Wager, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 55

Open-label placebo clinical trials: is it the rationale, the interaction or the pill?
Charlotte Blease, Michael H. Bernstein, Cosima Locher
BMJ evidence-based medicine (2019) Vol. 25, Iss. 5, pp. 159-165
Open Access | Times Cited: 54

Open-label placebos for menopausal hot flushes: a randomized controlled trial
Yiqi Pan, R. Meister, Bernd Löwe, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 39

Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis
Stephen V. Faraone, Jeffrey H. Newcorn, Andrea Cipriani, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 212-219
Closed Access | Times Cited: 34

Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review
Elisa Frisaldi, Aziz Shaibani, Fabrizio Benedetti, et al.
BMJ Open (2023) Vol. 13, Iss. 10, pp. e077243-e077243
Open Access | Times Cited: 13

Working with patients’ treatment expectations – what we can learn from homeopathy
Marcel Wilhelm, Christiane Hermann, Winfried Rief, et al.
Frontiers in Psychology (2024) Vol. 15
Open Access | Times Cited: 5

Thirty Years of Neuroscientific Investigation of Placebo and Nocebo: The Interesting, the Good, and the Bad
Fabrizio Benedetti, Elisa Frisaldi, Aziz Shaibani
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 323-340
Closed Access | Times Cited: 29

Even when you know it is a placebo, you experience less sadness: First evidence from an experimental open-label placebo investigation
Alannah Hahn, Annelie C. Göhler, Christiane Hermann, et al.
Journal of Affective Disorders (2022) Vol. 304, pp. 159-166
Closed Access | Times Cited: 20

Changes in neural processing and evaluation of negative facial expressions after administration of an open-label placebo
Anne Schienle, Isabella Unger, Daniela Schwab
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19

Beyond Needling: Integrating a Bayesian Brain Model into Acupuncture Treatment
Beomku Kang, Da-Eun Yoon, Yeonhee Ryu, et al.
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 192-192
Open Access

Bayes meets Hegel: the dialectics of belief space and the active inference of suffering
Valery Krupnik
Synthese (2025) Vol. 205, Iss. 3
Closed Access

Open-label placebos reduce test anxiety and improve self-management skills: A randomized-controlled trial
Michael Schaefer, Claudia Denke, Rebecca Harke, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 32

The role of placebos in family medicine: Implications of evidence and ethics for general practitioners
Charlotte Blease
Australian Journal of General Practice (2019) Vol. 48, Iss. 10, pp. 700-705
Open Access | Times Cited: 32

Page 1 - Next Page

Scroll to top